ROYALTY PHARMA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.27 USD | -2.19% |
|
-2.92% | -2.92% |
Chart calendar Royalty Pharma plc
342a32c4254bed1c.r-BYfuiwlR2cHeKNE9PUt_oBLjDYlVAiAkg-vTpfnHc._oQeU9D620nkaNDEd4KL36l4cWmO7WQaQxhv11cG0R3ipAwwntLfZMl6gQ~8790b207a30aed951b07580615bddf21
Upcoming events on Royalty Pharma plc
Past events on Royalty Pharma plc
| 2024-05-15 06:00 pm | BofA Securities Health Care Conference |
| 2024-05-14 09:00 am | RBC Capital Markets Global Healthcare Conference |
| 2024-05-09 08:00 am | Q1 2024 Earnings Call |
| 2024-05-09 07:00 am | Q1 2024 Earnings Release |
| 2024-03-05 10:30 am | TD Cowen Health Care Conference |
| 2024-02-15 08:00 am | Q4 2023 Earnings Call |
| 2024-02-15 07:30 am | Q4 2023 Earnings Release |
| 2024-01-09 12:00 pm | JPMorgan Healthcare Conference |
| 2023-11-28 03:00 pm | Evercore ISI HealthCONx Conference |
| 2023-11-08 08:00 am | Q3 2023 Earnings Call |
| 2023-11-08 07:00 am | Q3 2023 Earnings Release |
| 2023-10-19 09:00 am | Business Update Call |
| 2023-09-12 12:55 pm | Morgan Stanley Global Healthcare Conference |
| 2023-09-06 11:20 am | Citi BioPharma Conference |
| 2023-08-08 08:00 am | Q2 2023 Earnings Call |
| 2023-08-08 07:00 am | Q2 2023 Earnings Release |
| 2023-06-22 09:00 am | Annual General Meeting |
| 2023-06-13 05:00 pm | Goldman Sachs Global Healthcare Conference |
| 2023-05-10 05:20 pm | BofA Securities Health Care Conference |
| 2023-05-09 08:00 am | Q1 2023 Earnings Call |
Past dividends on Royalty Pharma plc
| 2024-05-15 | Quarterly 0.21 USD |
| 2024-02-14 | Quarterly 0.21 USD |
| 2023-11-15 | Quarterly 0.2 USD |
| 2023-08-16 | Quarterly 0.2 USD |
| 2023-05-17 | Quarterly 0.2 USD |
| 2023-02-14 | Quarterly 0.2 USD |
| 2022-11-16 | Quarterly 0.19 USD |
| 2022-08-17 | Quarterly 0.19 USD |
| 2022-05-18 | Quarterly 0.19 USD |
| 2022-02-16 | Quarterly 0.19 USD |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2 122 1 961 8.2% | 2 289 2 127 7.6% | 2 237 2 856 -21.69% | 2 355 2 978 -20.92% | 2 651 |
|
EBITDA Million USD | Released Forecast Spread | 1 621 1 616 0.34% | 1 944 1 933 0.56% | 2 566 2 554 0.45% | 2 806 2 734 2.62% | 2 492 |
|
EBIT Million USD | Released Forecast Spread | 1 598 1 628 -1.86% | 1 921 1 899 1.15% | 2 560 1 953 31.08% | 2 806 2 720 3.15% | 2 111 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 230 1 793 -87.17% | 1 700 635 167.84% | 1 411 |
|
Net income Million USD | Released Forecast Spread | 975 1 532 -36.37% | 620 937 -33.85% | 43,0 569 -92.44% | 1 135 707 60.5% | 942 |
|
EPS USD | Released Forecast Spread | 1,61 2,56 -37.26% | 1,02 1,54 -33.68% | 0,07 1,37 -94.83% | 2,53 1,58 60.13% | 2,11 |
| Announcement Date | 17/02/21 | 15/02/22 | 15/02/23 | 15/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 562 593 -5.22% | 536 534 0.39% | 573 610 -6.12% | 566 1 097 -48.42% | 684 630 8.63% | 538 537 0.26% | 536 618 -13.29% | 596 675 -11.64% | 568 709 -19.94% | 603 | 683 | 714 | ||
|
EBITDA Million USD | Released Forecast Spread | 556 532 4.45% | 480 482 -0.34% | 548 535 2.48% | 983 982 0.14% | 1 044 854 22.19% | 498 498 -0.08% | 582 603 -3.37% | 682 636 7.16% | 656 638 2.89% | 592 | 652 | 625 | 701 | 640 |
|
EBIT Million USD | Released Forecast Spread | 550 529 3.89% | 480 481 -0.15% | 548 482 13.79% | 983 796 23.44% | 1 044 577 80.87% | 498 487 2.24% | 582 567 2.72% | 682 630 8.27% | 656 541 21.2% | 396 | 404 | 868 | ||
|
Net income Million USD | Released Forecast Spread | 52,0 335 -84.47% | 305 289 5.45% | 143 199 -27.97% | -456 -60,9 -648.96% | 494 -170 389.84% | 5,00 240 -97.91% | 56,9 | 35,5 | 817 | |||||
|
EPS USD | Released Forecast Spread | 0,09 0,80 -89.22% | 0,50 0,70 -28.21% | 0,24 0,46 -48.7% | -0,75 -0,14 -436.6% | 1,10 -0,38 389.47% | 0,54 | 0,13 | 0,08 | 1,82 | |||||
| Announcement Date | 05/05/22 | 04/08/22 | 08/11/22 | 15/02/23 | 09/05/23 | 08/08/23 | 08/11/23 | 15/02/24 | 09/05/24 | - | - | - | - | - |
More events
Past sector events for Royalty Pharma plc
| 2024-05-17 08:52 am | J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-17 04:28 am | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-15 10:05 am | MANKIND PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-15 01:30 am | DERMAPHARM HOLDING SE: Q1 2024 Earnings Release |
| 2024-05-15 07:40 am | CRESCO LABS INC.: Q1 2024 Earnings Release |
| 2024-05-15 03:03 am | GRANULES INDIA LIMITED: Q4 2024 Earnings Release |
| 2024-05-14 | EISAI CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-14 05:43 pm | LIQUIDIA CORPORATION: Q1 2024 Earnings Release |
| 2024-05-14 04:52 am | BORA PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-14 01:30 am | BAYER AG: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RPRX Stock
- Calendar Royalty Pharma plc
